Aktiesnakken — August 2011
-
det er da temmeligt provokerende at påtage sig den type objektiv tone. Det ville tænde mig helt vildt op i det røde felt hvis jeg sad i EPO
-
-
Så må jeg spørge igen. Det dokument er det så alligevel ikke et partsindlæg?
-
men en slags foreløbig udtalelse, og er den "conclusion" så noget der indstilles fra EPO til EPO?
-
ok tak doctor
-
hvordan læser I så den conclusion?
-
jeg er klar på at det ikke er den endelige afgørelse....
-
man må vel forestille sig at bioporto ønsker at holde en oral proceeding i februar?
-
patentjura er det værste nørkleri
-
hahaha.
-
never buy into a lawsuit må suppleres med never buy into a patent fight
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind